Goyal R K, Bangaru R A, Lakkad N B, Rao M V
Department of Pharmacology, L.M. College of Pharmacy, Ahmedabad.
Indian J Physiol Pharmacol. 1996 Jul;40(3):220-4.
Diabetes-mellitus was induced in rats by single intravenous injection of (45 mg/kg) streptozotocin (STZ). STZ diabetic rats showed hypertension, decreased cardiac functions, cardiomyopathy and hypercholesterolemia observed at the end of six weeks. Chronic treatment with atenolol (10 mg/kg) for six weeks in the diabetic rats reduced the elevated blood pressure, but failed to prevent STZ induced other complications. Chronic treatment with prazosin (1 mg/kg, po) in the diabetic rats, reduced the elevated blood pressure and also partially prevented hypercholesterolemia, cardiac dysfunctions and in particular the cardiomyopathy. The results suggest that prazosin may be a better option as compared to atenolol in hypertension when it is associated with diabetes mellitus.
通过单次静脉注射(45毫克/千克)链脲佐菌素(STZ)诱导大鼠患糖尿病。在六周结束时观察到,STZ诱导的糖尿病大鼠出现高血压、心脏功能下降、心肌病和高胆固醇血症。用阿替洛尔(10毫克/千克)对糖尿病大鼠进行六周的慢性治疗可降低升高的血压,但未能预防STZ诱导的其他并发症。用哌唑嗪(1毫克/千克,口服)对糖尿病大鼠进行慢性治疗,可降低升高的血压,还能部分预防高胆固醇血症、心脏功能障碍,尤其是心肌病。结果表明,在高血压合并糖尿病时,与阿替洛尔相比,哌唑嗪可能是更好的选择。